Horse Pastures: How Much Tall Fescue If Too Much?

Horse owners and managers have known for many years that endophyte infected tall fescue can cause a variety of issues with late term pregnant mares. Research has shown that grazing pure stands induces extreme physiological changes, while grazing pastures completely free of E+ tall fescue is virtually safe. However few pastures are pure stands or completely free of tall fescue. We know that the “danger level” changes over the seasons and that management can greatly reduce the risk of mares grazing infected pastures. Understanding what is “too much” can help us weigh the risks of symptoms to the cost of removal

Novel Approaches to Developing On-Farm Biomass Production Systems

Energy security and climate change are issues facing many countries today. Finding clean, renewable fuel sources has provided a challenge to look beyond the obvious and search for new ways to use old resources. Switchgrass (Panicum virgatum L.) is a warm season grass native to many parts of the United States. In 2007, the University of Kentucky (UK) College of Agriculture started a collaborative project with the UK Cooperative Extension, farmers in northern Kentucky, Kentucky Forage and Grassland Council and East Kentucky Power Cooperative to explore and demonstrate how switchgrass can be grown, harvested and utilized in an economical and environmentally friendly way (Greenwell 2012a,b). This pilot project was funded by the KY Agricultural Development Fund and successfully established 60 ha of switchgrass between 2007-2011 and produced \u3e 500 t of biomass that was combusted for electricity production. Switchgrass was chosen as the biomass crop of choice for this area for a variety of reasons. It can be grown on marginal soils that are not well suited to row crops. It produces high yields with relatively low inputs and can be harvested with equipment that is common on typical US farms. Because it is a native grass, there is little concern of it becoming invasive and it provides wildlife habitat for local animal species. Additionally, when harvested at a vegetative stage, it produces high quality forage

Characterization of Norovirus and Other Human Enteric Viruses in Sewage and Stool Samples Through Next-Generation Sequencing.

This study aimed to optimize a method to identify human enteric viruses in sewage and stool samples using random primed next-generation sequencing. We tested three methods, two employed virus enrichment based on the binding properties of the viral capsid using pig-mucin capture or by selecting viral RNA prior to library preparation through a capture using the SureSelect target enrichment. The third method was based on a non-specific biophysical precipitation with polyethylene glycol. Full genomes of a number of common human enteric viruses including norovirus, rotavirus, husavirus, enterovirus and astrovirus were obtained. In stool samples full norovirus genome were detected as well as partial enterovirus genome. A variety of norovirus sequences was detected in sewage samples, with genogroup II being more prevalent. Interestingly, the pig-mucin capture enhanced not only the recovery of norovirus and rotavirus but also recovery of astrovirus, sapovirus and husavirus. Documenting sewage virome using these methods provides information for molecular epidemiology and may be useful in developing strategies to prevent further spread of viruses

Hydroxyl as a Tracer of H2 in the Envelope of MBM40

We observed 51 positions in the OH 1667 MHz main line transitions in the translucent, high latitude cloud MBM40. We detected OH emission in 8 out of 8 positions in the molecular core of the cloud and 24 out of 43 in the surrounding, lower extinction envelope and periphery of the cloud. Using a linear relationship between the integrated OH line intensity and E(B-V), we estimate the mass in the core, the envelope, and the periphery of the cloud to be 4, 8, and 5 solar masses. As much as a third of the total cloud mass may be found in the in the periphery (E(B-V) $<$ 0.12 mag) and about a half in the envelope (0.12 $\le$ E(B-V) $\le$ 0.17 mag). If these results are applicable to other translucent clouds the OH 1667 MHz line is an excellent tracer of gas in very low extinction regions and high-sensitivity mapping of the envelopes of molecular clouds may reveal the presence of significant quantities of molecular mass.Comment: 26 pages, 3 figures, and 5 table

Barriers to enrollment in a randomized controlled trial of hydrocortisone for cardiovascular insufficiency in term and late preterm newborn infants.

ObjectiveTo analyze reasons for low enrollment in a randomized controlled trial (RCT) of the effect of hydrocortisone for cardiovascular insufficiency on survival without neurodevelopmental impairment (NDI) in term/late preterm newborns.Study designThe original study was a multicenter RCT. Eligibility: ⩾34 weeks' gestation, &lt;72 h old, mechanically ventilated, receiving inotrope. Primary outcome was NDI at 2 years; infants with diagnoses at high risk for NDI were excluded. This paper presents an analysis of reasons for low patient enrollment.ResultsTwo hundred and fifty-seven of the 932 otherwise eligible infants received inotropes; however, 207 (81%) had exclusionary diagnoses. Only 12 infants were randomized over 10 months; therefore, the study was terminated. Contributing factors included few eligible infants after exclusions, open-label steroid therapy and a narrow enrollment window.ConclusionDespite an observational study to estimate the population, very few infants were enrolled. Successful RCTs of emergent therapy may require fewer exclusions, a short-term primary outcome, waiver of consent and/or other alternatives

Adenosine infusion increases plasma levels of VEGF in humans

BACKGROUND: Many in vitro studies have shown that adenosine (Ado) can induce vascular endothelial growth factor (VEGF) mRNA and protein expression and stimulate endothelial proliferation. In the present study, we seek to determine whether Ado can increase circulating levels of VEGF protein in the intact human. METHODS: Five outpatients 49.3 ± 6.7 years of age and weighing 88.2 ± 8.5 kg were selected. They were given a 6 min intravenous infusion of Ado (0.14 mg kg(-1 )min(-1)) in conjunction with sestamibi myocardial perfusion scans. Mean blood pressure (MBP, calculated from systolic and diastolic values) and heart rate (HR) were determined before Ado infusion and every 2 min for the next 10 min. Plasma VEGF concentrations (ELISA) were determined immediately before Ado infusion and 1 h, 2 h, and 8 h after the infusion. RESULTS: Plasma VEGF concentration averaged 20.3 ± 2.0 pg ml(-1 )prior to Ado infusion, and increased to 62.7 ± 18.1 pg ml(-1 )at 1 h post- infusion (p < 0.01). VEGF plasma concentration returned to basal levels 2 h after infusion (23.3 ± 3.4 pg ml(-1)). MBP averaged 116 ± 7 mmHg and heart rate averaged 70 ± 7 prior to Ado infusion. MBP decreased by a maximum of ~22% and HR increased by a maximum of ~17% during the infusion. CONCLUSION: We conclude from these preliminary findings that intravenous infusion of adenosine can increase plasma levels of VEGF in humans